FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205651635> ?p ?o ?g. }

• W4205651635 abstract "Background: The use of corticosteroids may help control the cytokine storm occurring in acute respiratory failure due to the severe form of COVID-19. We evaluated the postacute effect of corticosteroids used during the acute phase, such as impairment in pulmonary function parameters, on day 120 (D120)-follow-up, in participants who survived over 28 days. Methods: This is a parallel, double-blind, randomized, placebo-controlled phase IIb clinical trial carried out between April 18 and October 9, 2020, conducted in hospitalized patients with clinical-radiological suspicion of COVID-19, aged 18 years or older, with SpO2 ≤ 94% on room air or requiring supplementary oxygen, or under invasive mechanical ventilation (IMV) in a referral center in Manaus, Western Brazilian Amazon. Intravenous methylprednisolone (MP) (0.5 mg/kg) was given two times daily for 5 days to these patients. The primary outcome used for this study was pulmonary function testing at day 120 follow-up visit. Results: Out of the total of surviving patients at day 28 (n = 246) from the Metcovid study, a total of 118 underwent satisfactory pulmonary function testing (62 in the placebo arm and 56 in the MP arm). The supportive treatment was similar between the placebo and MP groups (seven [11%] vs. four [7%]; P = 0.45). At hospital admission, IL-6 levels were higher in the MP group (P < 0.01). Also, the need for ICU (P = 0.06), need for IMV (P = 0.07), and creatine kinase (P = 0.05) on admission also tended to be higher in this group. In the univariate analysis, forced expiratory volume on 1st second of exhalation (FEV1) and forced vital capacity (FVC) at D120 follow-up were significantly higher in patients in the MP arm, being this last parameter also significantly higher in the multivariate analysis independently of IMV and IL-6 levels on admission. Conclusion: The use of steroids for at least 5 days in severe COVID-19 was associated with a higher FVC, which suggests that hospitalized COVID-19 patients might benefit from the use of MP in its use in the long-term, with less pulmonary restrictive functions, attributed to fibrosis. Trial Registration: ClinicalTrials.gov, Identifier: NCT04343729." @default.
• W4205651635 created "2022-01-25" @default.
• W4205651635 creator A5001446475 @default.
• W4205651635 creator A5002275313 @default.
• W4205651635 creator A5003601874 @default.
• W4205651635 creator A5009196420 @default.
• W4205651635 creator A5013669206 @default.
• W4205651635 creator A5018940657 @default.
• W4205651635 creator A5027477114 @default.
• W4205651635 creator A5034783945 @default.
• W4205651635 creator A5039716928 @default.
• W4205651635 creator A5049859188 @default.
• W4205651635 creator A5050845396 @default.
• W4205651635 creator A5052871521 @default.
• W4205651635 creator A5053587411 @default.
• W4205651635 creator A5055840657 @default.
• W4205651635 creator A5059452672 @default.
• W4205651635 creator A5068323773 @default.
• W4205651635 creator A5068617807 @default.
• W4205651635 creator A5070083154 @default.
• W4205651635 creator A5073578820 @default.
• W4205651635 creator A5075934187 @default.
• W4205651635 creator A5077065332 @default.
• W4205651635 creator A5082610607 @default.
• W4205651635 creator A9999999999 @default.
• W4205651635 date "2021-11-30" @default.
• W4205651635 modified "2023-10-15" @default.
• W4205651635 title "Short-Course of Methylprednisolone Improves Respiratory Functional Parameters After 120 Days in Hospitalized COVID-19 Patients (Metcovid Trial): A Randomized Clinical Trial" @default.
• W4205651635 cites W1594758689 @default.
• W4205651635 cites W1862839341 @default.
• W4205651635 cites W2054076340 @default.
• W4205651635 cites W2056914680 @default.
• W4205651635 cites W2098062494 @default.
• W4205651635 cites W2119968951 @default.
• W4205651635 cites W2139110166 @default.
• W4205651635 cites W2150691073 @default.
• W4205651635 cites W2154552532 @default.
• W4205651635 cites W2170558722 @default.
• W4205651635 cites W2321386606 @default.
• W4205651635 cites W2439880544 @default.
• W4205651635 cites W2617620062 @default.
• W4205651635 cites W2768680636 @default.
• W4205651635 cites W2769689735 @default.
• W4205651635 cites W2771707664 @default.
• W4205651635 cites W2937437085 @default.
• W4205651635 cites W2949609519 @default.
• W4205651635 cites W2975416296 @default.
• W4205651635 cites W2981067716 @default.
• W4205651635 cites W3004626187 @default.
• W4205651635 cites W3005403371 @default.
• W4205651635 cites W3009885589 @default.
• W4205651635 cites W3011610993 @default.
• W4205651635 cites W3013967887 @default.
• W4205651635 cites W3020946865 @default.
• W4205651635 cites W3025586365 @default.
• W4205651635 cites W3027918021 @default.
• W4205651635 cites W3033897450 @default.
• W4205651635 cites W3036042332 @default.
• W4205651635 cites W3036127506 @default.
• W4205651635 cites W3036451913 @default.
• W4205651635 cites W3036453504 @default.
• W4205651635 cites W3036853141 @default.
• W4205651635 cites W3037268105 @default.
• W4205651635 cites W3043552652 @default.
• W4205651635 cites W3043654491 @default.
• W4205651635 cites W3045718031 @default.
• W4205651635 cites W3046212633 @default.
• W4205651635 cites W3046300278 @default.
• W4205651635 cites W3048510827 @default.
• W4205651635 cites W3074796735 @default.
• W4205651635 cites W3082355253 @default.
• W4205651635 cites W3085008014 @default.
• W4205651635 cites W3087116491 @default.
• W4205651635 cites W3091355259 @default.
• W4205651635 cites W3094913430 @default.
• W4205651635 cites W3097201842 @default.
• W4205651635 cites W3106772834 @default.
• W4205651635 cites W3111343279 @default.
• W4205651635 cites W3129128302 @default.
• W4205651635 cites W3131622812 @default.
• W4205651635 cites W3197653778 @default.
• W4205651635 cites W3205080610 @default.
• W4205651635 cites W4210642183 @default.
• W4205651635 cites W4245666729 @default.
• W4205651635 doi "https://doi.org/10.3389/fmed.2021.758405" @default.
• W4205651635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34917633" @default.
• W4205651635 hasPublicationYear "2021" @default.
• W4205651635 type Work @default.
• W4205651635 citedByCount "11" @default.
• W4205651635 countsByYear W42056516352022 @default.
• W4205651635 countsByYear W42056516352023 @default.
• W4205651635 crossrefType "journal-article" @default.
• W4205651635 hasAuthorship W4205651635A5001446475 @default.
• W4205651635 hasAuthorship W4205651635A5002275313 @default.
• W4205651635 hasAuthorship W4205651635A5003601874 @default.
• W4205651635 hasAuthorship W4205651635A5009196420 @default.
• W4205651635 hasAuthorship W4205651635A5013669206 @default.
• W4205651635 hasAuthorship W4205651635A5018940657 @default.
• W4205651635 hasAuthorship W4205651635A5027477114 @default.
• W4205651635 hasAuthorship W4205651635A5034783945 @default.

• next